Pfizer/BioNTech, Moderna mRNA vaccinations ongoing. J&J approved, not ordered. Supply picking up. Not yet approved: AstraZeneca, Curevac and Novavax. Switzerland has ordered over 30m doses for 8m people
BY CANTON: LAB-CONFIRMED CASES IN the past fortnight per 100K population—Similar to last week. Worst still in Uri. Dark end of scale up from 937 to 989.
BY CANTON: LAB-CONFIRMED HOSPITALISATION in the past fortnight per 100K population—Mixed picture. Worst in Uri. Numbers up. Dark end of scale up from 26.15 to 46.3
BY CANTON: DEATHS (which lag case numbers) tell yet another story—Overall numbers down slightly. Uri much worse. Dark end of scale down from 21.8 to 16.35.
LATEST: “Calculated risk” of partial relaxation Apr 19. Some restrictions remain. No further relaxation at last until May 26. Vaccinations accelerate slightly. R number down again. US lists Switzerland “Level 4: do not travel”
Pfizer/BioNTech, Moderna mRNA vaccinations ongoing. J&J approved, not ordered. Supply picking up. Approval waiting: AstraZeneca, Curevac and Novavax. Switzerland has ordered over 30m doses for 8m people
Pfizer/BioNTech, Moderna mRNA vaccinations ongoing. Supply picking up. Still waiting for approval: AstraZeneca, Curevac and Novavax. Switzerland has ordered over 30m doses for 8m people
Pfizer/BioNTech, Moderna mRNA vaccinations ongoing. Supply picking up. Still waiting for approval: AstraZeneca, Curevac and Novavax. Switzerland has ordered over 30m doses for 8m people
2/10
Vaccinations and virus variants
“Fully” = second dose
Steady growth, deliveries up
Delivered: 2.1m=23.9% (from 1.7m)
Administered: 1.4m=17.8% (from 1.2m)
Fully: 577K=6.7% (from 507K)
1. The WTO SPS Agreement is “as relevant and applicable today as [ever], and [continues] to safeguard the right for Members to take measures necessary for the protection of human, animal or plant life or health”
The SPS Committee improves implementation via transparency
2/4
2. But the world is changing. The draft proposes a new work programme (don’t yawn)—but not negotiating new obligations or amending the SPS Agreement
3. Interesting: the countries NOT on the list—eg EU, Iceland, Norway, Switzerland, UK. Why? …
Pfizer/BioNTech, Moderna mRNA vaccinations ongoing. Pfizer supply delayed. Still waiting for approval: AstraZeneca, Curevac and Novavax. Switzerland has ordered over 30m doses for 8m people
2/10
Vaccinations, virus variants
“Fully” = second dose
Steady growth, deliveries up
Delivered: 1.7m=19.8% (from 1.4m)
Administered: 1.4m=15.6% (from 1.2m)
Fully: 507K=5.9% (from 433K)